China Stock Market Rout Deepens: Falls 14 of 15 Weeks Despite Rescue
China's domestic equity market is caught in one of the most protracted downturns in its history, sliding in 14 of the past 15 weeks and wiping out months of artificial intelligence-driven gains despite increasingly forceful intervention from Beijing. After logging a 12-week losing streak culminating in October's steepest monthly drop in more than a decade—during which the blue-chip CSI 300 Index tumbled over 20 percent from its late-June peak into a technical bear market, while Shanghai's semiconductor-focused STAR 50 Index plunged roughly 47 to 48 percent from its peak—Chinese equities enjoyed only a brief one-week reprieve at the start of November before sellers regained control. The relentless slide has forced authorities to dust off their 2024 market-stabilization playbook: the People's Bank of China (PBOC) has rolled out low-cost liquidity facilities to fund corporate share buybacks and institutional equity purchases, state-backed investment funds known collectively as the "National Team" have stepped up exchange-traded fund (ETF) buying, and financial regulators have issued informal "window guidance" urging brokerages and large domestic funds to curtail net equity sales. Yet market analysts note that unlike earlier sell-offs commonly blamed on foreign hedge funds or quantitative traders, domestic institutional dynamics are playing a pivotal role in the current rout. According to Hong Liang, founder of Xiwang (Shiva) Capital Group, major Chinese insurers poured capital into soaring technology shares during July's boom only to trim their positions in late September, compounding downward pressure alongside shrinking leveraged margin trading and roughly CNY 90 billion in foreign Stock Connect outflows between July and September. Compounding the dilemma, state-owned insurance giants—which Beijing has long encouraged to act as long-term market anchors—now face mounting solvency and earnings strain of their own, with China Life Insurance having lifted its equity allocation to 19.2 percent by mid-year (up from 16.9 percent in 2025) and China's five largest listed insurers reporting sharply weaker third-quarter profits amid market volatility. For global investors, emerging-market fund managers, and market watchers across Mumbai, New Delhi, Bengaluru, Chennai, Hyderabad, Kolkata, Lucknow, Hong Kong, and Singapore, Beijing's struggle underscores that liquidity injections alone cannot cure sluggish domestic demand, deflationary pressures, and weak corporate earnings.
Anatomy of China's Historic Stock Market Sell-Off and Rescue Measures
Having endured at least three severe bear cycles over the past decade—in 2018, 2024, and now late 2026—Chinese equities face a convergence of technical, regulatory, and macroeconomic headwinds. The table below outlines the key market indicators, institutional pressures, and policy interventions shaping Beijing's latest rescue effort:
| Dimension / Indicator | Verified Market & Policy Data (2026) | Impact on Investor Sentiment & Market Stability |
| Benchmark & Tech Index Losses | CSI 300 fell >20% from its late-June 2026 peak into a bear market (worst October drop in 10+ years); STAR 50 plunged ~47%–48% from its peak; market down 14 of past 15 weeks. | Heavy unwinding in AI hardware and semiconductor stocks (which accounted for over 40% of A/H-share market cap) dragged broader indices near 16-month lows. |
| PBOC & "National Team" Rescue | PBOC activated low-cost funding for share buybacks and institutional liquidity; state-backed "National Team" accelerated purchases; regulators issued "window guidance". | Provided intermittent intraday floors, but failed to spark a durable reversal in retail or institutional risk appetite. |
| Shifting Sellers & Insurer Strain | China Life Insurance raised stock allocation to 19.2% (vs. 16.9% in 2025); China's top 5 listed insurers posted weak Q3 profits; CNY 90B Q3 foreign Stock Connect outflows. | Insurers balancing capital ratios and policyholder claims risk becoming forced sellers if losses deepen, blunting regulatory nudges to hold losing positions. |
| Macro & Structural Headwinds | Slower October factory output, subdued household consumption, lingering property-sector drag, cut 2026 EPS forecasts (-4%+), and Announcement No. 21 offshore-trust tax. | Highlighted that sustainable recovery depends on reviving domestic demand and corporate profitability rather than administrative directives alone. |
Why State-Owned Insurers Are Caught Between Policy Directives and Balance-Sheet Risk
For years, Chinese policymakers have leaned heavily on state-backed insurers and pension funds to inject patient, long-term capital into domestic equities. Encouraged by regulatory incentives, giants like China Life Insurance expanded their stock exposure—including heavy bets on artificial intelligence plays—to 19.2 percent of investment assets by June 2026.
However, prolonged equity drawdowns create an acute dilemma for insurers: they must safeguard solvency margins and capital buffers to honor policyholder claims and financial obligations. With third-quarter profits across China's five largest listed insurers severely dented by stock-market losses and China Pacific Insurance Group executives acknowledging a far more complex investment environment requiring tighter short-term volatility management, analysts warn that institutional buyers enlisted to stabilize the market could paradoxically be forced to pare equity risk if prices keep sliding.
Structural Roots: Why Liquidity Playbooks Keep Falling Short in Beijing
The fact that China has required emergency state stock-market rescues three times in a single decade—in 2018, 2024, and 2026—points to deeper economic frictions beyond trading mechanics. Persistent property-market weakness, cautious household spending, fierce corporate price wars eroding profit margins, and policy shocks such as July's Announcement No. 21 tax on offshore family trusts (which prompted founder share sales ahead of the October 22 settlement deadline) have steadily chipped away at earnings visibility. Until Beijing pairs market support with tangible demand stimulus and stronger corporate earnings growth, investor confidence is likely to remain fragile.